Latest Remuneration And Governance News

Surefire Resources has appointed Dr Andrew Whitehead as its new CEO following the resignation of Managing Director Paul Burton, signalling a fresh chapter for the mining company.

Stanmore Resources Limited posted a net loss of US$47.2 million for 2025, impacted by a 21% revenue decline due to lower coal prices despite record production and cost efficiencies. The company declared a fully franked final dividend of US 8.9 cents per share.

Iluka Resources posted a net loss of $288 million in 2025 amid subdued mineral sands demand but progressed key projects including the Balranald mine commissioning and Eneabba rare earths refinery construction.

Genetic Signatures has appointed Anne Lockwood as interim Managing Director, bringing extensive financial expertise to guide the company through a critical transition period.

InVert Graphite has completed its maiden drilling program at the Kumba deposit in Tanzania, revealing wide zones of high-grade graphite near surface and positioning the Morogoro Project for further advancement.

FleetPartners Group Limited reported a 3.2% revenue increase to $786.2 million for FY2025, despite a 3.3% decline in net profit after tax to $75.3 million. The company completed its Accelerate program, delivering $6 million in annualised cost savings and declared a final unfranked dividend of 13.6 cents per share.

Dyno Nobel reported a modest revenue dip but a solid 5.6% rise in net profit excluding one-off items for FY25, completing key divestments and advancing its transformation program.

Cluey Ltd has reported its strongest-ever underlying EBITDA alongside improved cash flow, while ramping up investments in AI-powered product development set to launch in 2026.

Ainsworth Game Technology announces the immediate resignation of CEO Harald Neumann and appoints COO Ryan Comstock as acting CEO while searching for a permanent replacement.

Boss Energy has appointed Matthew Dusci as Managing Director and CEO, marking a leadership transition aimed at driving operational focus and production growth at its Honeymoon uranium project.

Mayne Pharma reported a 5% revenue increase to $408.1 million for FY25 but posted a net loss of $93.8 million, narrowing from the prior year. The company’s planned acquisition by Cosette Pharmaceuticals faces legal hurdles, delaying completion.

Harvey Norman Holdings Limited reported strong FY25 financial results, driven by growth in franchisee sales, property portfolio appreciation, and digital investments. The company’s integrated retail, franchise, property, and digital system across multiple countries underpins its sustained shareholder returns.